<?xml version="1.0" encoding="UTF-8"?>
<fig id="ijms-20-06261-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>Protective effect of NC-5 on mice infected with A/FM/1/47 (H1N1) virus. The ICR mice were infected with influenza A virus (8 × LD
   <sub>50</sub>), and ten mice in each group received placebo, NC-5 or oseltamivir phosphate (OS) twice daily for 5 days. (
   <bold>A</bold>) Survival rate. (
   <bold>B</bold>) Body weight. On day 5 p.i., five mice per group were sacrificed for lung pathology examinations. (
   <bold>C</bold>) Lung index. (
   <bold>D</bold>) Histological lung injury scores of mice in each group. (
   <bold>E</bold>) H &amp; E staining of lung tissues (
   <italic>n</italic> = 5). Data are presented as the mean ± S.D. of three independent experiments, * 
   <italic>p</italic> &lt;0.05, ** 
   <italic>p</italic> &lt;0.01, *** 
   <italic>p</italic> &lt;0.001 compared with the placebo group.
  </p>
 </caption>
 <graphic xlink:href="ijms-20-06261-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
